Cytomegalovirus (CMV) - Wake Research

Cytomegalovirus (CMV)

CYTOMEGALOVIRUS (CMV) VACCINE STUDY

What is CMV?

Cytomegalovirus, shortened to CMV, is a leading cause of birth defects around the world. CMV is a common viral infection that usually goes unnoticed or only causes mild symptoms in most people. But if a woman becomes infected with CMV while she is pregnant, she can pass the infection to her unborn baby. This can cause her child to suffer long-term disability due to birth defects, including hearing loss, or even death in very severe cases. Currently, there is no approved vaccine against CMV.

Let us be the generation that stands up to cytomegalovirus (CMV), a highly contagious viral infection that can harm an unborn child. Learn more about a clinical trial for a potential vaccine.

To qualify, you must be:

  • A female aged 16 or 17
  • In generally good health
  • In close contact with at least one child 5 years of age or younger for at least 8 hours a week, if age 20 or older
  • Not pregnant or planning on becoming pregnant within the next 9 months

Qualified participants will receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • Compensation up to $1550 for time and travel

Why Participate?

Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.

Experience

The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.

Safety

Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.

Clinical Research Center of Nevada

Study Hotline
+1-702-723-2208

Main Office
+1-702-893-8968

Our Hours
Mon-Fri: 8AM to 4.30PM

Headquarters 
2020 Wellness Way, Suite 206
Las Vegas, NV 89106

Contact us for study location details